HOME >> BIOLOGY >> NEWS
Virginia Bioinformatics Institute to develop Tomato Metabolite Database

Blacksburg, Va. A researcher at the Virginia Bioinformatics Institute (VBI) at Virginia Tech is developing a database and computational tools to help scientists learn more about how certain genes in tomatoes affect the crop's flavor and nutritional value.

The Tomato Metabolite Database, which is being implemented by Zhangjun Fei, a senior bioinformatics scientist in VBI's Cyberinfrastructure Group, will be used to store a wide range of information and data about tomato, including microarray and metabolite profiling data as well as information on metabolic pathways. This resource will be used to identify key genes involved in the synthesis of essential metabolites that impact tomato flavor and the quality of its nutrients.

Fei's work is part of a collaboration with Harry Klee, professor of horticultural science at the University of Florida and principal investigator for the project, and Jim Giovannoni, adjunct professor of plant biology at the Boyce Thompson Institute at Cornell University and research molecular biologist at the United States Department of Agriculture (USDA) Agricultural Research Service's Plant, Soil and Nutrition Laboratory. The work is funded by a $2-million grant from the National Science Foundation.

Research groups led by Klee and Giovannoni will use the information provided by the Tomato Metabolite Database to characterize the functions of those genes identified as being responsible for genetic variation in tomato using state-of-the-art RNA interference (RNAi) technology. RNAi technology allows scientists to silence or turn down the specific function of a gene within a cell and represents a powerful approach to accurately establish gene function on a large scale.

"The development of this database will allow researchers the world over to develop and test hypotheses regarding the regulation of flavor, nutrition and quality metabolites in edible crop tissues," said Klee.

By identifying the highly complex
'"/>

Contact: Susan Bland
subland@vbi.vt.edu
540-231-7912
Virginia Tech
6-Apr-2006


Page: 1 2

Related biology news :

1. Virginia Tech researchers to study poplar tree as model biomass crop
2. Fire ants are emerging nuisance for Virginians
3. Virginia Techs System X supercomputer provides super tool for simulation of cell division
4. Asian Soybean Rust found in Virginia, but not a threat to current crop
5. Virginia Tech chemists create new polymers by adding DNA base pairs
6. Pregnant drivers, football players safer thanks to a top Virginia Tech researcher
7. Virginia Tech student selected to meet Nobel Laureates
8. Virginia study urges early emphasis on science
9. Award supports Virginia Tech research to reduce vehicle emissions, create biofuel
10. Oswaldo Cruz Foundation, Virginia Bioinformatics Institute sign agreement...
11. Virginia Tech to host Biodiversity Conservation in Agriculture Symposium

Post Your Comments:
(Date:1/22/2015)... Technology Showcase, Hall E -   EyeLock Inc. , a ... will showcase its EyeLock ID technology integrated in a 3D ... Oak Ridge National Laboratory (ORNL) at the 2015 ... authentication technology is being used to validate the driver and ...
(Date:1/22/2015)... , Jan. 16, 2015  A man-made form of ... and other mental capabilities in adults with mild cognitive ... study led by researchers at Wake Forest Baptist Medical ... diagnosed with amnesic mild cognitive impairment (MCI) or mild ...
(Date:1/22/2015)... YORK and POINT ROBERTS, Washington ... news source covering leading sectors including technology and tech stocks, ... Privacy marketplace featuring master pickpocket and security consultant Apollo ... is stolen and talks about the Wocket™ biometric smart wallet, ...
Breaking Biology News(10 mins):EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 2EyeLock Debuts First Iris Authentication Technology Embedded in 3D Printed Automobile 3Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 2Nasal Spray with Insulin Equivalent Shows Promise as Treatment for Adults with Mild Cognitive Impairment, Alzheimer's Dementia 3Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 2Apollo Robbins Talks about the Illusion of Personal Safety and How Easily Your Wallet is Stolen; If a Wocket Wallet is Stolen the Thief Can't do Anything With it! 3
(Date:2/27/2015)... , Feb. 27, 2015 A ... the NCATS rare-diseases portfolio " in Science ... new financing technique to reduce the risk associated ... and potentially unlock new levels of funding for ... product of a unique collaboration between scientists at ...
(Date:2/27/2015)... 27, 2015  Pfenex Inc. (NYSE MKT: PFNX), a ... therapeutics, today announced that it will be presenting at ... March 2 nd at 3pm PST. Patrick Lucy, chief ... discussing the current state of the biosimilar industry landscape ... For more information on CALBIO 2015 and ...
(Date:2/26/2015)... -- S&P Capital IQ (MHFI) announced today that it ... Therapeutics Holdings Inc . MabVax Therapeutics ... focused on the development of vaccine and antibody-based therapies ... cancer. MabVax has discovered a pipeline of human monoclonal ... by patients who have been immunized against targeted cancers. ...
(Date:2/26/2015)... 2015   Regulus Therapeutics Inc . (NASDAQ: ... and development of innovative medicines targeting microRNAs, today announced ... Chief Executive Officer of Regulus, will present a company ... Annual Healthcare Conference on Wednesday, March 4, 2015 at ... the Boston Marriott Copley Place.  The ...
Breaking Biology Technology:New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 2New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 3New Financing Technique May Hold Key to Unlocking Funding for Rare Diseases 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 2S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 3S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 4S&P Capital IQ Initiates Coverage on MabVax Therapeutics Holdings Inc. in S&P Capital IQ Factual Stock Reports 5Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3
Cached News: